Review and critical appraisal of the indications for cardiac magnetic resonance imaging in the ESC guidelines.
Bernhard L GerberPublished in: Acta cardiologica (2023)
Cardiac MRI has made significant advances in the past decade, becoming an important technique for the evaluation of various cardiac pathologies. The aim of this document is to review the current indications for performing cardiac MRI based on the current ESC guidelines for STEMI, NSTEMI, chronic coronary artery disease, heart failure, arrhythmias, sudden cardiac death, valvular heart disease, pericardial disease and congenital heart disease. The review discusses the diagnostic and prognostic value of cMR for numerous cardiac diseases, and its important value in assessing structural heart disease and predicting arrhythmia risk. Additionally, it reflects upon the appropriateness of the guidelines and points out areas where the indications should be revised in future editions, based on the author's personal opinion. It is suggested that guideline criteria for the use of cMR should be more explicit to promote its use and lead to more specific reimbursements. However, further studies are needed to even better document the value of cMR in the future.
Keyphrases
- left ventricular
- congenital heart disease
- heart failure
- coronary artery disease
- magnetic resonance imaging
- clinical practice
- contrast enhanced
- atrial fibrillation
- percutaneous coronary intervention
- pulmonary hypertension
- cardiovascular disease
- computed tomography
- magnetic resonance
- coronary artery bypass grafting
- st elevation myocardial infarction
- case control